{'fraction_non_alphanumeric': 0.020569620253164556, 'fraction_numerical': 0.00949367088607595, 'mean_word_length': 5.267326732673268, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical stage T1c prostate cancer: Pathologic outcomes following radical prostatectomy in black and white men

The incidence of prostate cancer in black men is 50% to 70% higher than among age‐matched white men. Black men have a twofold higher mortality rate and overall tend to have higher serum prostate‐specific antigen (PSA) levels than white men. To determine whether racial differences exist in men whose prostate cancer was diagnosed based solely on an elevated serum PSA level, we compared clinical and pathologic features in black and white men undergoing radical prostatectomy (RP) for clinical stage T1c prostate cancer.